Coal linkage: KSERC nod for changes in bidding papers

The Kerala State Electricity Board (KSEB) will now be able to go ahead with the bidding process for procuring 500 megawatts (MW) round-the-clock (RTC) power using coal allocated under the Scheme for Harnessing and Allocating Koyala Transparently in India (SHAKTI). The Kerala State Electricity Regulatory Commission (KSERC) has approved a set of deviations proposed by the KSEB in the model bidding documents issued by the Union Power Ministry related to the request for qualification, request for proposal, and the power supply agreement.
The Centre had allocated the coal linkage to Kerala under Part B (iv) of the Union Coal Ministry's SHAKTI scheme last year. Para B (iv) of the scheme provides for the allocation of coal linkages for fresh power purchase agreements to States. Kerala has been allocated coal from the IB Field and Talcher Field of Coal India-subsidiary MCL Coal Company.
Earlier this year, the State government had given its nod for appointing Central PSU PFC Consulting Ltd (PFCCL) as the transactional advisor for the long-term procurement of power for a 25 years. Major deviations proposed by the KSEB were related to the delivery point of power, minimum capacity, payment security mechanism, fuel supply agreement and calculation of fixed charges.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Mint

26 minutes ago

• Mint

India may cut duties on US shrimp imports

NEW DELHI : India may lower duties on shrimp imports to support reciprocal trade alignment in its trade agreement with the US, according to two people close to the discussions. The commerce ministry is closely monitoring the US Department of Commerce's actions on countervailing duty (CVD) and anti-dumping duty (ADD) on shrimp imports from India, the officials said on the condition of anonymity. India is keeping a 'close watch" on these developments and may consider recalibrating its own duties on shrimp imports if the US undertakes a revision, especially as the two nations work to resolve trade irritants and harmonize tariff frameworks under the Bilateral Trade Agreement (BTA), the first official said. Also Read: Mint Exclusive: India-US trade deal before 8 July, talks next week Such a move, the second official suggested, would demonstrate India's commitment to fair trade practices and its willingness to align with a key trading partner, provided domestic interests, particularly those of the shrimp farming and processing industry, are safeguarded. Any adjustment on India's part would also take into account global price trends and the competitive landscape in key markets like the US, Japan, and the EU. However, if the deal is signed in time, these duties will be recalibrated according to the mutually agreed-upon terms. Also Read: India, US lay foundation for trade give-and-take Queries sent to the commerce ministry remained unanswered until press time. India's seafood exports Shrimp is one of India's top seafood exports, with the US being its largest market. At present, Indian shrimp exports to the US face an effective customs duty of 17.7%, including 5.77% CVD and 1.8% ADD, and a 10% baseline tariff imposed by the US on 2 April. In exchange, India levies a 30% duty on US-origin Vannamei shrimp, also known as Pacific white shrimp. Competing countries, on the other hand, face significantly higher duties. For instance, Ecuador is subject to a CVD of 7.55%, while Vietnam faces a CVD of 2.84%. Although Vietnam's CVD is lower than India's, it is now also facing a preliminary anti-dumping duty of 35%, imposed in June 2025. Similarly, Thailand's CP Foods (Charoen Pokphand Foods PCL), one of the world's largest producers of feed and shrimp, has been hit with a preliminary ADD of 57.6%. In 2024-25, India exported marine products worth over $6 billion, with frozen shrimp accounting for a major share, according to data from the Marine Products Export Development Authority (MPEDA). In comparison, India imported seafood worth $13.76 million from the US in 2023-24, according to the commerce ministry. Also Read: Will India press for an early harvest in trade talks with US? 'The lowering of tariffs, especially CVD and ADD, would give a fillip to Indian shrimp exports. We hope the government will take up the issue during bilateral talks," said Pawan Kumar G., president, Seafood Exporters Association of India. Window of opportunity With the BTA negotiations entering a crucial phase, trade analysts see this as an opportunity for both sides to make coordinated changes that reduce trade friction. The 10% base tariff and the proposed additional 16% reciprocal tariff are expected to severely impact India's seafood exports to the US, as these products account for nearly a third of India's global seafood exports. India is projected to suffer a 20.2% decline, amounting to a $404.3 million loss, especially as Canadian seafood continues to enjoy duty-free access under the USMCA trade pact, said a report by the Global Trade Research Initiative (GTRI). Processed meat and fish exports are also expected to be hit hard, with estimated losses of $83.1 million, or 14.2%, as tariffs rise from 2.6% to 31.2%, the report added.

Business Standard

39 minutes ago

• Business Standard

Suven Life Sciences Ltd Slides 3.06%, BSE Healthcare index Shed 1.34%

Suven Life Sciences Ltd has added 6% over last one month compared to 0.02% fall in BSE Healthcare index and 0.02% drop in the SENSEX Suven Life Sciences Ltd fell 3.06% today to trade at Rs 220. The BSE Healthcare index is down 1.34% to quote at 42505.21. The index is down 0.02 % over last one month. Among the other constituents of the index, Syncom Formulations (India) Ltd decreased 2.97% and Concord Biotech Ltd lost 2.72% on the day. The BSE Healthcare index went up 15.59 % over last one year compared to the 5.82% surge in benchmark SENSEX. Suven Life Sciences Ltd has added 6% over last one month compared to 0.02% fall in BSE Healthcare index and 0.02% drop in the SENSEX. On the BSE, 155 shares were traded in the counter so far compared with average daily volumes of 1.08 lakh shares in the past one month. The stock hit a record high of Rs 272 on 12 Jun 2025. The stock hit a 52-week low of Rs 97.03 on 20 Jun 2024.

Time of India

4 hours ago

• Time of India

Granules India shares in focus after US FDA flags observation at Telangana API facility

Live Events Granules India share price target (You can now subscribe to our (You can now subscribe to our ETMarkets WhatsApp channel Shares of Granules India will be in focus on Monday after the company announced that its active pharmaceutical ingredient (API) facility in Telangana has received an observation from the US Food and Drug Administration (FDA) under Form a stock exchange filing, Granules India said the FDA completed an inspection at its API Unit-1 facility in Bonthapally, Sangareddy district, last to the FDA, Form 483 observations are issued when investigators observe practices or conditions that may potentially violate the Food, Drug and Cosmetic Act. However, a Form 483 does not constitute a final determination of non-compliance by the India said it will respond to the observation within the stipulated Bonthapally site is Granules India's largest API manufacturing facility for paracetamol. It also houses production units for Metformin and Guaifenesin APIs, the company to Trendlyne, the average analyst target price for Granules India is Rs 622, indicating an upside potential of about 28% from current levels. Of the 8 analysts tracking the stock, the consensus rating is 'Strong Buy'.On the technical front, the Relative Strength Index (RSI) stands at 40.4, suggesting neutral to slightly bearish momentum. The stock continues to trade below its 20-day, 50-day, 100-day, and 200-day simple moving averages (SMAs), indicating continued India shares have declined around 19% year-to-date, but the stock has delivered a 66% return over the past two years. The company's market capitalisation currently stands at approximately Rs 11,808 crore.: Recommendations, suggestions, views, and opinions given by the experts are their own. These do not represent the views of Economic Times)